Letter to the Editor

Letter to the Editor

Interaction of Ondansetron, Escitalopram, and Highly Active Antiretroviral Therapy

June 18, 2020

In this letter to the editor, Dr Naguy comments on a case report previously published in the PCC.

Letter to the Editor

Depression as a Factor in Nonadherence in Schizophrenia

June 16, 2020

This letter comments on the article "Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia" by Kane and Correll.

Letter to the Editor

Drs Kane and Correll Reply

June 16, 2020

Drs Kane and Correll reply to the letter "Depression as a Factor in Nonadherence in Schizophrenia" by Hirakawa and Ishii.

Letter to the Editor

Five-Year Follow-Up of Adolescents With Conduct Disorder

June 4, 2020

The authors of this letter to the editor discuss a study of the adult clinical trajectories of a cohort of adolescents diagnosed with conduct disorder after referral to an...

Letter to the Editor

Intravenous Ketamine for Depressed Patients Unable to Receive ECT Due to Medical Risks

June 4, 2020

In this letter to the editor, the authors describe a small population of patients unable to receive ECT due to medical risks who received ketamine for depression.

Letter to the Editor

Unconjugated Bilirubin in Schizophrenia

April 23, 2020

In this letter to the editor, Dr Gama Marques discusses the use of unconjugated bilirubin as a biological marker for schizophrenia.